Merck's Biosimilar to AbbVie's Humira Wins FDA Approval - Medscape

Merck's Biosimilar to AbbVie's Humira Wins FDA Approval  Medscape

The U.S. Food and Drug Administration approved Merck & Co Inc's biosimilar to AbbVie Inc's blockbuster rheumatoid arthritis treatment Humira (adalimumab), ...



Comments

Popular posts from this blog

Fibromyalgia — Latest Stories — Pain News Network

Chronic Lyme arthritis: A mystery solved?

Epstein-Barr virus and autoimmune diseases